Nanoparticle-motivated gene delivery for ophthalmic application

Area of Science:

• Ophthalmology
• Gene Therapy
• Nanotechnology

Background:

• Ophthalmic gene therapy aims to treat ocular genetic diseases by manipulating gene expression in eye cells.
• Delivery of therapeutic nucleic acids (DNA, RNA) is hindered by degradation.
• Nanotechnology presents a promising solution for protecting and delivering these nucleic acids.

Purpose of the Study:

• To review current nanotechnology modalities for ocular gene delivery.
• To explore nonviral strategies for treating ophthalmic genetic diseases.

Main Methods:

• Review of existing literature on nanotechnology applications in ocular gene therapy.
• Analysis of nonviral gene delivery strategies for ophthalmic conditions.

Main Results:

• Nanotechnology acts as a protective shelter for therapeutic nucleic acids.
• It enables safe delivery to target ocular cells for protein expression modulation.
• Nanotechnology is a key strategy in ocular gene delivery.

Conclusions:

• Nanotechnology is a promising approach for overcoming challenges in ophthalmic gene therapy.
• It facilitates effective delivery of therapeutic genes to treat ocular diseases.